日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB-D melanoma: a phase 1/2 trial

新辅助抗PD-1单药治疗或联合抗TIGIT或溶瘤病毒治疗可切除的IIIB-D期黑色素瘤:一项1/2期试验

Dummer, Reinhard; Robert, Caroline; Scolyer, Richard A; Taube, Janis M; Tetzlaff, Michael T; Menzies, Alexander M; Hill, Andrew; Grob, Jean-Jacques; Portnoy, David C; Lebbe, Celeste; Khattak, Muhammad A; Cohen, Jonathan; Bar-Sela, Gil; Mehmi, Inderjit; Shapira-Frommer, Ronnie; Meyer, Nicolas; Webber, Andrea L; Ren, Yixin; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Long, Georgina V

Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial

可切除黑色素瘤新辅助治疗中,PD-1 和 LAG-3 靶向双特异性抗体与其他免疫检查点抑制剂联合疗法:一项随机 1b/2 期 Morpheus-Melanoma 试验

Long, Georgina V; Nair, Nitya; Marbach, Daniel; Scolyer, Richard A; Wilson, Sabine; Cotting, Denise; Staedler, Nicolas; Amaria, Rodabe N; Ascierto, Paolo Antonio; Tarhini, Ahmad A; Robert, Caroline; Hamid, Omid; Gaudy-Marqueste, Caroline; Lebbe, Celeste; Munoz-Couselo, Eva; Menzies, Alexander M; Pages, Cecile; Curigliano, Giuseppe; Mandala, Mario; Jessop, Nikki; Bader, Uwe; Perdicchio, Maurizio; Teichgräber, Volker; Muecke, Merlind; Markert, Christoph; Blank, Christian

Harnessing nutrient scarcity for enhanced CAR-T-cell potency and safety in solid tumors.

利用营养匮乏增强 CAR-T 细胞在实体瘤中的疗效和安全性

Manchon Enzo, Hirt Nell, Versier Benjamin, Soundiramourty Aravindhan, Juricek Ludmila, Lebbe Celeste, Battistella Maxime, Christen Yves, Mallet Jacques, Charron Dominique, Jabrane-Ferrat Nabila, Serguera Che, Al-Daccak Reem

Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma

一项针对晚期黑色素瘤、皮肤鳞状细胞癌、头颈部鳞状细胞癌或腺样囊性癌患者的瘤内注射CV8102的I期研究

Eigentler, Thomas; Thomas, Ioannis; Samoylenko, Igor; Erdmann, Michael; Heinzerling, Lucie; Ochsenreither, Sebastian; Krauss, Jürgen; Oberoi, Arjun; Robert, Caroline; Lebbe, Celeste; Martin-Liberal, Juan; Koch, Lukas; Richtig, Erika; Terheyden, Patrick; Weishaupt, Carsten; Mohr, Peter; Semiletova, Yulia; Perez, Casilda Llacer; Brossart, Peter; Bauernfeind, Franz Georg; Fluck, Michael; Poltoratskiy, Artem; Sekacheva, Marina; Soria, Ainara; Schmitt-Bormann, Beate; Gonzalez, Marina; Heß, Jana; Wengenmayer, Peter; Seibel, Tobias; Koch, Sven D; Quintini, Gianluca; Codó, Paula; Falk, Martin; Schönborn-Kellenberger, Oliver; Gnad-Vogt, Ulrike

Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanoma.

可溶性 CD27 可预测黑色素瘤对单独使用抗 PD-1 疗法的耐药性,但不能预测对同时使用抗 CTLA-4 疗法的耐药性

Sam Ikuan, Benhamouda Nadine, Biard Lucie, Da Meda Laetitia, Desseaux Kristell, Baroudjan Barouyr, Nakouri Ines, Renaud Marion, Sadoux Aurélie, Alkatrib Marina, Deleuze Jean-François, Battistella Maxime, Shen Yimin, Resche-Rigon Matthieu, Mourah Samia, Lebbe Celeste, Tartour Eric

Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network

放射治疗与附件癌预后因素:一项来自法国CARADERM网络的657例患者的回顾性研究

Zagala, Robin; Dalle, Stephane; Beylot-Barry, Marie; Meyer, Nicolas; Saiag, Philippe; Kramkimel, Nora; Lebbe, Celeste; Zehou, Ouidad; Amini-Adle, Mona; Grob, Jean-Jacques; Arnault, Jean-Philippe; Maubec, Eve; Granel-Brocard, Florence; Cribier, Bernard; Quereux, Gaelle; Brunet-Possenti, Florence; Dalac, Sophie; Dereure, Olivier; Drumez, Elodie; Mortier, Laurent; Battistella, Maxime; Jouary, Thomas

Modern Approach to Manage Patients With Kaposi Sarcoma

卡波西肉瘤患者的现代治疗方法

Bettuzzi, Thomas; Lebbe, Celeste; Grolleau, Chloé

When to stop immunotherapy for advanced melanoma: the emulated target trials

晚期黑色素瘤免疫疗法何时停止:模拟靶点试验

Amiot, Mathilde; Mortier, Laurent; Dalle, Stéphane; Dereure, Olivier; Dalac, Sophie; Dutriaux, Caroline; Leccia, Marie-Thérèse; Maubec, Eve; Arnault, Jean-Philippe; Brunet-Possenti, Florence; De Quatrebarbes, Julie; Granel-Brocard, Florence; Gaudy-Marqueste, Caroline; Pages, Cecile; Stoebner, Pierre-Emmanuel; Saiag, Philippe; Lesimple, Thierry; Dupuy, Alain; Legoupil, Delphine; Montaudié, Henri; Oriano, Bastien; Lebbe, Celeste; Porcher, Raphael

The features and management of acquired resistance to PD1-based therapy in metastatic melanoma

转移性黑色素瘤对PD-1靶向治疗产生耐药性的特征及管理

Hepner, Adriana; Versluis, Judith M; Wallace, Roslyn; Allayous, Clara; Brown, Lauren Julia; Trojaniello, Claudia; Gerard, Camille Lea; Jansen, Yanina Jl; Bhave, Prachi; Neyns, Bart; Haydon, Andrew; Michielin, Olivier; Mangana, Joanna; Klein, Oliver; Shoushtari, Alexander N; Warner, Allison Betof; Ascierto, Paolo Antonio; McQuade, Jennifer Leigh; Carlino, Matteo S; Zimmer, Lisa; Lebbe, Celeste; Johnson, Douglas B; Sandhu, Shahneen; Atkinson, Victoria; Blank, Christian U; Lo, Serigne N; Long, Georgina V; Menzies, Alexander M

Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results

贝培加地白介素联合纳武利尤单抗治疗未经治疗的晚期黑色素瘤:开放标签、III期PIVOT IO 001试验结果

Diab, Adi; Gogas, Helen; Sandhu, Shahneen; Long, Georgina V; Ascierto, Paolo A; Larkin, James; Sznol, Mario; Franke, Fabio; Ciuleanu, Tudor E; Pereira, Caio; Muñoz Couselo, Eva; Bronzon Damian, Fernanda; Schenker, Michael; Perfetti, Aldo; Lebbe, Celeste; Quéreux, Gaëlle; Meier, Friedegund; Curti, Brendan D; Rojas, Carlos; Arriaga, Yull; Yang, Haisu; Zhou, Ming; Ravimohan, Shruthi; Statkevich, Paul; Tagliaferri, Mary A; Khushalani, Nikhil I